Please login to the form below

Not currently logged in
Email:
Password:

Japan

This page shows the latest Japan news and features for those working in and with pharma, biotech and healthcare.

Tecentriq misses the mark in advanced ovarian cancer

Tecentriq misses the mark in advanced ovarian cancer

AZ is awaiting additional decisions on Imfinzi in first-line ES-SCLC in Europe and Japan before the end of the year, and the drug is already approved for this indication

Latest news

More from news
Approximately 48 fully matching, plus 883 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 106 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 34 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics